Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation
Prostate cancer (PCA) is one of the most prevalent types of male cancers. While current treatments for early-stage PCA are available, their efficacy is limited in advanced PCA, mainly due to drug resistance or low efficacy. In this context, novel valuable therapeutic opportunities may arise from the...
Saved in:
Main Authors: | Luca Pinzi (Author), Silvia Belluti (Author), Isabella Piccinini (Author), Carol Imbriano (Author), Giulio Rastelli (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group
by: Pasquale Linciano, et al.
Published: (2021) -
Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer
by: Fabiana Sélos Guerra, et al.
Published: (2021) -
Immunohistochemical expression of interlukin10 (IL10) and heat shock protein-90 (HSP-90) in prostatic carcinoma
by: Wasan Abdul-ilah Bakir, et al.
Published: (2020) -
Molecular Dynamics Simulations of Hsp90 with an Eye to Inhibitor Design
by: Giorgio Colombo, et al.
Published: (2012) -
Synthesis, DFT calculations, and anti-proliferative evaluation of pyrimidine and selenadiazolopyrimidine derivatives as dual Topoisomerase II and HSP90 inhibitors
by: Samar El-Kalyoubi, et al.
Published: (2023)